Prenetics Global Limited (NASDAQ:PRE – Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $5.40, but opened at $4.52. Prenetics Global shares last traded at $5.70, with a volume of 21,666 shares.
Wall Street Analysts Forecast Growth
Separately, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $60.00 target price on shares of Prenetics Global in a research note on Tuesday, September 26th.
Prenetics Global Stock Down 3.5 %
Prenetics Global (NASDAQ:PRE – Get Free Report) last issued its quarterly earnings data on Friday, September 15th. The company reported ($0.75) earnings per share for the quarter, topping the consensus estimate of ($0.90) by $0.15. Prenetics Global had a negative net margin of 29.53% and a positive return on equity of 10.23%. The company had revenue of $5.70 million for the quarter. As a group, research analysts forecast that Prenetics Global Limited will post -0.28 EPS for the current fiscal year.
Hedge Funds Weigh In On Prenetics Global
Hedge funds and other institutional investors have recently bought and sold shares of the company. Renaissance Technologies LLC acquired a new position in Prenetics Global in the first quarter valued at $30,000. Quinn Opportunity Partners LLC acquired a new position in Prenetics Global in the first quarter valued at $34,000. Geode Capital Management LLC acquired a new position in Prenetics Global in the first quarter valued at $43,000. Ieq Capital LLC acquired a new position in Prenetics Global in the first quarter valued at $46,000. Finally, Brown Advisory Inc. acquired a new position in Prenetics Global in the first quarter valued at $69,000. Institutional investors and hedge funds own 39.14% of the company’s stock.
About Prenetics Global
Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use.
- Five stocks we like better than Prenetics Global
- How to Invest in Hotel Stocks
- Buffett’s latest portfolio additions, trims, and cuts in Q3
- What Are Defense Contractor Stocks? How to Invest in Defense
- 5 reasons TJX Companies will hit new highs in 2024
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Game-changing news for Ambarella puts the market in reversal
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.